BioNTech

Highly Engaged Employees

BioNTech, founded in 2008 and headquartered in Mainz, Germany, is a clinical-stage biotechnology company specializing in the development and manufacturing of active immunotherapies. The firm focuses on patient-specific approaches to treat complex diseases, including cancer and infectious conditions. By leveraging a proprietary technology platform, BioNTech creates individualized treatments that harness the body's immune system to target specific biological markers.

The company maintains a robust operational footprint with 6 global locations and a workforce of 5,000-10,000 employees. This diverse team includes hundreds of scientists, engineers, and medical professionals dedicated to advancing biopharmaceutical innovation. Meet BioNTech's team to learn more about the leadership and organizational structure driving their research and development efforts. Their commitment to cutting-edge science is reflected in their extensive pipeline of therapeutic candidates and vaccine technologies.

BioNTech has demonstrated significant market growth, reporting annual revenue of $3.2B. The company’s financial stability is supported by a history of strategic funding rounds, including Series A and B investments, debt financing, and government grants. These resources facilitate the scaling of their manufacturing facilities and the acceleration of clinical trials. Explore financial highlights for detailed metrics regarding their fiscal performance and investment history.